Koshinski Asset Management Inc. grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 1.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,588 shares of the pharmacy operator’s stock after purchasing an additional 312 shares during the period. Koshinski Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $856,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Rise Advisors LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth about $27,000. Iron Horse Wealth Management LLC raised its stake in Walgreens Boots Alliance by 56.0% in the first quarter. Iron Horse Wealth Management LLC now owns 635 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 228 shares in the last quarter. GoalVest Advisory LLC raised its stake in Walgreens Boots Alliance by 10,828.6% in the second quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 758 shares in the last quarter. City State Bank purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $30,000. Finally, Tompkins Financial Corp raised its stake in shares of Walgreens Boots Alliance by 215.7% during the first quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator’s stock worth $42,000 after acquiring an additional 647 shares in the last quarter. Hedge funds and other institutional investors own 57.33% of the company’s stock.
Walgreens Boots Alliance Stock Down 1.6 %
NASDAQ WBA opened at $33.43 on Thursday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.43 and a current ratio of 0.78. The company has a market capitalization of $28.89 billion, a P/E ratio of 5.39, a P/E/G ratio of 1.47 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a one year low of $33.43 and a one year high of $55.00. The stock has a 50 day moving average price of $37.51 and a 200-day moving average price of $41.37.
Walgreens Boots Alliance Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, September 9th. Stockholders of record on Friday, August 19th were given a dividend of $0.48 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.48. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.74%. The ex-dividend date was Thursday, August 18th. Walgreens Boots Alliance’s dividend payout ratio is currently 30.97%.
Analyst Ratings Changes
Several research analysts recently commented on the stock. Credit Suisse Group decreased their target price on shares of Walgreens Boots Alliance from $52.00 to $43.00 and set a “neutral” rating on the stock in a research note on Friday, July 1st. Cowen decreased their target price on Walgreens Boots Alliance to $49.00 in a research report on Thursday, June 9th. Morgan Stanley reduced their price target on shares of Walgreens Boots Alliance from $43.00 to $39.00 and set an “underweight” rating for the company in a research report on Wednesday, July 6th. Royal Bank of Canada cut their price objective on Walgreens Boots Alliance from $46.00 to $42.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 5th. Finally, StockNews.com upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research note on Friday, August 19th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $46.25.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- General Mills: Superior Returns With Less Volatility
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.